Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GMAB | AZN | AMGN | GILD | BMY |
| Company | Genmab A/S ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 27.55 | 195.15 | 346.75 | 132.36 | 59.00 |
| High | 27.55 | 195.15 | 346.75 | 132.36 | 59.00 |
| Low | 27.55 | 195.15 | 346.75 | 132.36 | 59.00 |
| Latest | 27.55 | 195.15 | 346.75 | 132.36 | 59.00 |
| Change | -0.14 | +0.34 | +0.83 | -0.54 | +0.20 |
| % Change | -0.51% | +0.17% | +0.24% | -0.41% | +0.34% |
| Volume | 15,281 | 31,202 | 2,490 | 5,189 | 4,276 |
| 20-Day Average Volume | 1,645,549 | 1,796,435 | 2,346,750 | 4,993,679 | 9,174,134 |
| Previous Close | 27.69 | 194.81 | 345.92 | 132.90 | 58.80 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 27.66 | 199.18 | 349.22 | 137.91 | 59.17 |
| 20-Day Raw Stochastic | 48.77% | 50.43% | 47.94% | 8.73% | 35.56% |
| 20-Day Relative Strength | 47.40 | 47.90 | 45.42 | 37.83 | 50.13 |
| Weighted Alpha | +22.88 | +37.73 | +22.21 | +23.94 | +26.93 |
| Today's Opinion | 72% Sell | 72% Buy | 24% Buy | 24% Buy | 48% Buy |
| Previous Opinion | 56% Sell | 72% Buy | 24% Buy | 24% Buy | 48% Buy |
| Last Month's Opinion | 72% Sell | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.65% since 04/16/26 | -2.65% since 04/16/26 | -0.76% since 04/16/26 | -4.47% since 04/16/26 | +0.07% since 04/16/26 |
| Low | 26.89 on 04/21/26 | 194.80 on 04/22/26 | 340.06 on 04/21/26 | 131.34 on 04/22/26 | 57.79 on 04/21/26 |
| High | 28.87 on 04/17/26 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 139.76 on 04/17/26 | 60.48 on 04/17/26 |
| 1-Month | |||||
| %Chg | +7.28% since 03/23/26 | +6.02% since 03/23/26 | -0.86% since 03/23/26 | -3.63% since 03/23/26 | +3.51% since 03/23/26 |
| Low | 25.42 on 03/24/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 131.34 on 04/22/26 | 56.45 on 03/24/26 |
| High | 29.43 on 04/14/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -18.68% since 01/23/26 | +4.98% since 01/23/26 | +0.58% since 01/23/26 | -2.63% since 01/23/26 | +7.96% since 01/23/26 |
| Low | 24.95 on 03/20/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 131.34 on 04/22/26 | 54.21 on 01/29/26 |
| High | 34.68 on 01/27/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -7.77% since 10/23/25 | +17.00% since 10/23/25 | +18.39% since 10/23/25 | +9.62% since 10/23/25 | +34.61% since 10/23/25 |
| Low | 24.95 on 03/20/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 35.43 on 01/14/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 17,791,020 | 302,132,384 | 186,687,840 | 164,958,400 | 120,054,016 |
| Shares Outstanding, K | 642,507 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 3,720,000,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 963,000,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,058,000,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 31,000,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.97 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.05 on 02/17/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/14/26 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 17.46 | 21.37 | 15.78 | 16.35 | 9.66 |